Sort
25,944 grants matching “neurodegeneration”
Brain O2 defense during hibernation and arousal
$656,625University Of Alaska Fairbanks · R15 · FY2004 · NS
Neuronal cell-cycle re-entry and neurodegeneration
$656,416Shanthini Sockanathan · Johns Hopkins University · R01 · FY2021 · AG
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
$656,300Cynthia Ann Munro · Johns Hopkins University · R01 · FY2022 · AG
Comparative neurotoxicity of PFAS
$656,288Jennifer L. Freeman · Purdue University · R01 · FY2025 · ES
Comparative neurotoxicity of PFAS
$656,288Jennifer L. Freeman · Purdue University · R01 · FY2024 · ES
Core B: Clinical Core
$656,142Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · P30 · FY2022 · AG
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION
$656,132Elan D Louis · Yale University · R01 · FY2016 · NS
The Alzheimer's Disease Resiliome: Pathway Analysis and Drug Discovery.
$656,115Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2022 · AG
Large-Scale Genomic Analysis of Aging-Related Cognitive Change Prior to Dementia Onset
$655,978Elliot Max Tucker-Drob · University Of Texas At Austin · R01 · FY2024 · AG
Mechanisms of Prion Protein Toxicity
$655,922David A Harris · Boston University Medical Campus · R01 · FY2016 · NS
Core B: Clinical Core
$655,752Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · P30 · FY2023 · AG
Insulin Resistance and Accelerated Cognitive Aging
$655,403Natalie L Rasgon · Stanford University · R01 · FY2019 · AG
The Role of GPNMB in Parkinson's Disease.
$655,329Frank Soldner · Albert Einstein College Of Medicine · R01 · FY2024 · NS
Project 1: Tau metabolism: molecular chaperones, targeting and proteolysis
$655,218Aimee Kao · University Of California, San Francisco · U54 · FY2023 · NS
Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers
$655,175Robert A Stern · Boston University Medical Campus · R01 · FY2012 · NS
In vivo assessment of meningeal inflammation and its clinical impact in multiple sclerosis by 7 Tesla MRI
$655,017Daniel M Harrison · University Of Maryland Baltimore · R01 · FY2018 · NS
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
$654,898Robert G Kalb · Northwestern University At Chicago · R01 · FY2025 · NS
Defining the Role of Poly ADP-ribose in Biomolecular Condensation in ALS and FTLD
$654,638Sua Myong · Boston Children'S Hospital · R01 · FY2024 · AG
Mechanisms of chimeric DPR production and toxicity in c9ALS/FTD
$654,423Zachary Thomas McEachin · Emory University · R01 · FY2024 · NS
Computational Model of Neurocognitive Impairment in Multiple Sclerosis
$654,287James Francis Sumowski · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
A Transgenic Monkey: Inherited Neurodegenerative Disease
$654,284Emory University · R24 · FY2005 · RR
Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis
$654,245Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Neurosteroid Treatment for OP Intoxication
$654,238Doodipala Samba Reddy · Texas A&M University Health Science Ctr · U01 · FY2016 · NS
Mechanisms and intervention of cGAS signaling in brain trauma-induced neuroinflammation and neurodegeneration
$654,218Junfang Wu · University Of Maryland Baltimore · R01 · FY2025 · NS
Cell-type and organelle-specific multi-omics platform for the study of brain aging
$654,019Marta M Lipinski · University Of Maryland Baltimore · R33 · FY2025 · AG